Health · Hardware
PEDRA Technology
PEDRA Technology is a Singapore-based medical device company that built the PEDRA Xauron Perfusion System, the first device to deliver real-time, quantitative measurement of deep-tissue blood perfusion in the foot during vascular procedures. Aimed at physicians treating peripheral arterial disease (PAD) and critical limb threatening ischemia (CLTI), the laser-based, non-invasive system gives interventionalists objective feedback in the angio suite - where they have historically relied on subjective interpretation of X-ray images. The company raised a $4.7M Series A in 2020 and won FDA Breakthrough Device Designation in 2021.